{
    "title": "U.S. FDA declines to approve Y-mAbs's pediatric cancer drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11492959/U-S-FDA-declines-approve-Y-mAbss-pediatric-cancer-drug.html",
    "date": "2022-12-01",
    "keywords": [
        "drug",
        "treatment",
        "cancer",
        "companys",
        "omburtamab",
        "danyelza",
        "bone",
        "dec",
        "health",
        "regulator",
        "thursday",
        "form",
        "nerve",
        "trading",
        "ymabs",
        "food",
        "response",
        "letter",
        "crl",
        "development",
        "program",
        "decision",
        "vote",
        "october",
        "evidence",
        "survival",
        "outcome",
        "panel",
        "meeting",
        "executive",
        "officer",
        "thomas",
        "gad",
        "statement",
        "fda",
        "strength",
        "uncertainty",
        "trial",
        "company",
        "revenue",
        "fluid",
        "brain",
        "cord",
        "hand",
        "neuroblastoma",
        "marrow",
        "reporting",
        "aditya",
        "samal",
        "leo",
        "bengaluru",
        "editing",
        "kalluvila",
        "maju",
        "samuel",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}